Aistil (Eyestill)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceSodium hyaluronateSodium hyaluronate
Similar drugsTo uncover
  • Aistil
    drops d / eye 
    SIIFI SpA     Italy
  • Sinoart®
    solution in / Sust. 
    FarmSirma Soteks, ZAO     Russia
    • Dosage form: & nbspeye drops
    Composition:

    Per 100 ml:

    Active substance: sodium hyaluronate - 0.150 g.

    Excipients (tubes-dropper 0.3 ml): sodium dihydrogen phosphate monohydrate 0.004 g, sodium hydrophosphate dodecahydrate 0.056 g, sodium chloride 0.680 g, water purified to 100.0 ml

    Auxiliary substances (vials of a dropper 10 ml): sodium dihydrogen phosphate monohydrate 0.004 g of sodium hydrogen phosphate dodecahydrate 0.056 g Sodium chloride 0.680 g Benzalkonium chloride 0.005 g Purified water ad 100.0 ml
    Description:

    A clear, colorless solution.

    Pharmacotherapeutic group:Eye Protector
    ATX: & nbsp

    D.03   Preparations for the treatment of wounds and ulcers

    Pharmacodynamics:Sodium hyaluronate - saline high molecular weight polysaccharide contained in eye tissues and other tissues and fluids of the human body, and has a pronounced ability to bind water molecules. The aqueous sodium hyaluronate solution has the required viscosity, and high adhesive properties relative to the front surface of the eye, thereby forming a uniform surface on the cornea, continuing for a long time predrogovichnuyu tear film, which gradually leaches during blinking.Thus, an aqueous solution of sodium hyaluronate helps stabilize the tear film and increases its hydrating properties: it does not cause a decrease in visual acuity.
    Pharmacokinetics:

    Sodium hyaluronate is not absorbed and is not distributed in the tissues of the eye due to its high molecular weight.

    Indications:

    Symptomatic treatment of the "dry eye" syndrome.

    Contraindications:

    - Hypersensitivity to the components of the drug;

    - children under 18 years of age (due to lack of data on efficiency and safety).

    Pregnancy and lactation:

    Possible use during pregnancy and during breastfeeding, because sodium hyaluronate is not absorbed (see section "Pharmacokinetics").

    Dosing and Administration:

    It is recommended to instill 1 drop to 6 times a day in the lower conjunctival sac of each eye. Frequency of instillation and duration of the drug is determined individually by an ophthalmologist.

    Side effects:

    Allergic reactions are possible (redness, burning, irritation of eyelids or conjunctiva of the eye), lacrimation, development of superficial point keratitis. Side effects are transient.

    Overdose:

    There is no information about drug overdose.

    Interaction:

    It is not recommended to use eye drops "Aistil" simultaneously with any other ophthalmic preparations. In case of necessity of joint application of eye drops "Aistil" with other ophthalmic preparations it is necessary to make a break between instillation "Aistil" and application of other preparation.

    Special instructions:

    Before using the drug, contact lenses should be removed and reinserted 15 minutes after instillation of eye drops "Aistil".

    Drops, packaged in tubes of droppers of 0.3 ml, do not contain a preservative, so they should be used immediately after opening; The tube-dropper with the remnants of the drug should be discarded.

    When instilling, avoid contacting the tip of the dropper dropper or a dropper with eye surface and skin.

    The bottle-dropper must be closed with a screw cap after each use of the drug.

    Effect on the ability to drive transp. cf. and fur:

    Not applicable.

    Form release / dosage:

    Eye drops 0.15%.

    Packaging:

    Tubes-dropper: 0.3 ml of solution in a tube-dropper from low-pressure polyethylene.5 tubes of intravenous drips per strip. 1 strip per sealed polyester / aluminum / polyethylene bag. For 4 packages together with instructions for use in a pack of cardboard.

    Drip bottles: 10 ml of the drug in a bottle-dropper made of low-density polyethylene, sealed with a screw cap made of high pressure polyethylene. A protective cap of low pressure polyethylene is put on top of the cap. By 1 a flask-dropper along with instructions for use in a pack of cardboard.

    Storage conditions:

    Store at a temperature not exceeding 25 ° C.

    Keep out of the reach of children.

    Shelf life:

    2 of the year.

    Do not use after the expiration date printed on the package. Flasks-droppers: after opening the bottle the drug should be used within 28 days.
    Terms of leave from pharmacies:On prescription
    Registration number:LP-000353
    Date of registration:22.02.2011 / 19.05.2016
    Expiration Date:Unlimited
    The owner of the registration certificate:SIIFI SpASIIFI SpA Italy
    Manufacturer: & nbsp
    Representation: & nbspNovaMedika, OOONovaMedika, OOORussia
    Information update date: & nbsp23.06.2017
    Illustrated instructions
      Instructions
      Up